Global Colorectal Cancer Screening Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: May-2021 | Id: MACRC-66435 | Geographical Scope: Global | Publisher: HNY Research
The global Colorectal Cancer Screening market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Abbott Quidel Exact Sciences Clinical Genomics Technologies Novigenix SA Epigenomics Inc Sysmex Hemosure Inc Roche Siemens By Types: Stool-based Tests Colonoscopy CT Colonography Others By Applications: Hospitals Independent Diagnostic Labs Others Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Colorectal Cancer Screening Revenue 1.5 Market Analysis by Type 1.5.1 Global Colorectal Cancer Screening Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Stool-based Tests 1.5.3 Colonoscopy 1.5.4 CT Colonography 1.5.5 Others 1.6 Market by Application 1.6.1 Global Colorectal Cancer Screening Market Share by Application: 2022-2027 1.6.2 Hospitals 1.6.3 Independent Diagnostic Labs 1.6.4 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Colorectal Cancer Screening Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Colorectal Cancer Screening Market Players Profiles 3.1 Abbott 3.1.1 Abbott Company Profile 3.1.2 Abbott Colorectal Cancer Screening Product Specification 3.1.3 Abbott Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Quidel 3.2.1 Quidel Company Profile 3.2.2 Quidel Colorectal Cancer Screening Product Specification 3.2.3 Quidel Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Exact Sciences 3.3.1 Exact Sciences Company Profile 3.3.2 Exact Sciences Colorectal Cancer Screening Product Specification 3.3.3 Exact Sciences Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Clinical Genomics Technologies 3.4.1 Clinical Genomics Technologies Company Profile 3.4.2 Clinical Genomics Technologies Colorectal Cancer Screening Product Specification 3.4.3 Clinical Genomics Technologies Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Novigenix SA 3.5.1 Novigenix SA Company Profile 3.5.2 Novigenix SA Colorectal Cancer Screening Product Specification 3.5.3 Novigenix SA Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Epigenomics Inc 3.6.1 Epigenomics Inc Company Profile 3.6.2 Epigenomics Inc Colorectal Cancer Screening Product Specification 3.6.3 Epigenomics Inc Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Sysmex 3.7.1 Sysmex Company Profile 3.7.2 Sysmex Colorectal Cancer Screening Product Specification 3.7.3 Sysmex Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Hemosure Inc 3.8.1 Hemosure Inc Company Profile 3.8.2 Hemosure Inc Colorectal Cancer Screening Product Specification 3.8.3 Hemosure Inc Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Roche 3.9.1 Roche Company Profile 3.9.2 Roche Colorectal Cancer Screening Product Specification 3.9.3 Roche Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Siemens 3.10.1 Siemens Company Profile 3.10.2 Siemens Colorectal Cancer Screening Product Specification 3.10.3 Siemens Colorectal Cancer Screening Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Colorectal Cancer Screening Market Competition by Market Players 4.1 Global Colorectal Cancer Screening Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Colorectal Cancer Screening Revenue Market Share by Market Players (2016-2021) 4.3 Global Colorectal Cancer Screening Average Price by Market Players (2016-2021) 5 Global Colorectal Cancer Screening Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Colorectal Cancer Screening Market Size (2016-2021) 5.1.2 Colorectal Cancer Screening Key Players in North America (2016-2021) 5.1.3 North America Colorectal Cancer Screening Market Size by Type (2016-2021) 5.1.4 North America Colorectal Cancer Screening Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Colorectal Cancer Screening Market Size (2016-2021) 5.2.2 Colorectal Cancer Screening Key Players in East Asia (2016-2021) 5.2.3 East Asia Colorectal Cancer Screening Market Size by Type (2016-2021) 5.2.4 East Asia Colorectal Cancer Screening Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Colorectal Cancer Screening Market Size (2016-2021) 5.3.2 Colorectal Cancer Screening Key Players in Europe (2016-2021) 5.3.3 Europe Colorectal Cancer Screening Market Size by Type (2016-2021) 5.3.4 Europe Colorectal Cancer Screening Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Colorectal Cancer Screening Market Size (2016-2021) 5.4.2 Colorectal Cancer Screening Key Players in South Asia (2016-2021) 5.4.3 South Asia Colorectal Cancer Screening Market Size by Type (2016-2021) 5.4.4 South Asia Colorectal Cancer Screening Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Colorectal Cancer Screening Market Size (2016-2021) 5.5.2 Colorectal Cancer Screening Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Colorectal Cancer Screening Market Size by Type (2016-2021) 5.5.4 Southeast Asia Colorectal Cancer Screening Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Colorectal Cancer Screening Market Size (2016-2021) 5.6.2 Colorectal Cancer Screening Key Players in Middle East (2016-2021) 5.6.3 Middle East Colorectal Cancer Screening Market Size by Type (2016-2021) 5.6.4 Middle East Colorectal Cancer Screening Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Colorectal Cancer Screening Market Size (2016-2021) 5.7.2 Colorectal Cancer Screening Key Players in Africa (2016-2021) 5.7.3 Africa Colorectal Cancer Screening Market Size by Type (2016-2021) 5.7.4 Africa Colorectal Cancer Screening Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Colorectal Cancer Screening Market Size (2016-2021) 5.8.2 Colorectal Cancer Screening Key Players in Oceania (2016-2021) 5.8.3 Oceania Colorectal Cancer Screening Market Size by Type (2016-2021) 5.8.4 Oceania Colorectal Cancer Screening Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Colorectal Cancer Screening Market Size (2016-2021) 5.9.2 Colorectal Cancer Screening Key Players in South America (2016-2021) 5.9.3 South America Colorectal Cancer Screening Market Size by Type (2016-2021) 5.9.4 South America Colorectal Cancer Screening Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Colorectal Cancer Screening Market Size (2016-2021) 5.10.2 Colorectal Cancer Screening Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Colorectal Cancer Screening Market Size by Type (2016-2021) 5.10.4 Rest of the World Colorectal Cancer Screening Market Size by Application (2016-2021) 6 Global Colorectal Cancer Screening Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Colorectal Cancer Screening Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Colorectal Cancer Screening Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Colorectal Cancer Screening Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Colorectal Cancer Screening Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Colorectal Cancer Screening Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Colorectal Cancer Screening Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Colorectal Cancer Screening Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Colorectal Cancer Screening Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Colorectal Cancer Screening Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Colorectal Cancer Screening Consumption by Countries 7 Global Colorectal Cancer Screening Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Colorectal Cancer Screening (2022-2027) 7.2 Global Forecasted Revenue of Colorectal Cancer Screening (2022-2027) 7.3 Global Forecasted Price of Colorectal Cancer Screening (2022-2027) 7.4 Global Forecasted Production of Colorectal Cancer Screening by Region (2022-2027) 7.4.1 North America Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.3 Europe Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.7 Africa Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.9 South America Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Colorectal Cancer Screening Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Colorectal Cancer Screening by Application (2022-2027) 8 Global Colorectal Cancer Screening Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Colorectal Cancer Screening by Country 8.2 East Asia Market Forecasted Consumption of Colorectal Cancer Screening by Country 8.3 Europe Market Forecasted Consumption of Colorectal Cancer Screening by Countriy 8.4 South Asia Forecasted Consumption of Colorectal Cancer Screening by Country 8.5 Southeast Asia Forecasted Consumption of Colorectal Cancer Screening by Country 8.6 Middle East Forecasted Consumption of Colorectal Cancer Screening by Country 8.7 Africa Forecasted Consumption of Colorectal Cancer Screening by Country 8.8 Oceania Forecasted Consumption of Colorectal Cancer Screening by Country 8.9 South America Forecasted Consumption of Colorectal Cancer Screening by Country 8.10 Rest of the world Forecasted Consumption of Colorectal Cancer Screening by Country 9 Global Colorectal Cancer Screening Sales by Type (2016-2027) 9.1 Global Colorectal Cancer Screening Historic Market Size by Type (2016-2021) 9.2 Global Colorectal Cancer Screening Forecasted Market Size by Type (2022-2027) 10 Global Colorectal Cancer Screening Consumption by Application (2016-2027) 10.1 Global Colorectal Cancer Screening Historic Market Size by Application (2016-2021) 10.2 Global Colorectal Cancer Screening Forecasted Market Size by Application (2022-2027) 11 Global Colorectal Cancer Screening Manufacturing Cost Analysis 11.1 Colorectal Cancer Screening Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Colorectal Cancer Screening 12 Global Colorectal Cancer Screening Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Colorectal Cancer Screening Distributors List 12.3 Colorectal Cancer Screening Customers 12.4 Colorectal Cancer Screening Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer